Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06693700 · ClinicalTrials.gov registry record · NA

A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

A NA study of Smoking Cessation and Smoking, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
8
Study locations

NCT06693700: Recruiting NA study of Smoking Cessation and Smoking, sponsored by Memorial Sloan Kettering Cancer Center.

NCT06693700 is a NA study of Smoking Cessation and Smoking that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 10 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (98% lower). The trial reports 8 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06693700, a NA study of Smoking Cessation and Smoking, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.

Primary Outcome

Assess the feasibility and acceptability of collecting environmental data on biomarkers of household air quality (AQ) and smoke exposure using low-cost, AQMs as an intermediate endpoint of a smoke-free-home.

Interventions

  • OTHER Indoor Air Quality Monitor AirGradient ONE

Study Locations (8)

New York

  • Memorial Sloan Kettering Suffolk-Commack (Consent only) - Commack
  • Memorial Sloan Kettering Westchester (Consent only) - Harrison
  • City College of New York (Data Collection AND Data Analysis) - New York
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (Consent only) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge (Consent only) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent only) - Middletown
  • Memorial Sloan Kettering Bergen (Consent only) - Montvale

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-11-14
Est. Completion 2027-11-14
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What NCT06693700 shows while recruiting

NCT06693700 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (98% lower).

The record links to 10 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Indoor Air Quality Monitor AirGradient ONE is the first listed.

NCT06693700 lists 8 locations in 2 states (New York, New Jersey).

Frequently Asked Questions

What is clinical trial NCT06693700 about?

NCT06693700 is a clinical study titled "A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home". The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.

What is the current status of trial NCT06693700?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-11-14. Estimated completion is 2027-11-14.

What conditions does trial NCT06693700 study?

This clinical trial studies the following conditions: Smoking Cessation, Smoking, Tobacco Use, Tobacco Smoking, Smoking Behaviors.

What interventions are being tested in trial NCT06693700?

The interventions under investigation include: Indoor Air Quality Monitor AirGradient ONE (OTHER).

Who is sponsoring clinical trial NCT06693700?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06693700 being conducted?

This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06693700's enrollment target sits among peer trials

10 185th of 188 higher than 3 of 188 other Smoking Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06693700, the US trial registry maintained by the National Library of Medicine. NCT06693700 (small enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.